Application Information

This drug has been submitted to the FDA under the reference 203314/001.

Names and composition

"TRESIBA" is the commercial name of a drug composed of INSULIN DEGLUDEC.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
203314/001 TRESIBA INSULIN DEGLUDEC SOLUTION/SUBCUTANEOUS 300 UNITS per 3ML (100 UNITS per ML)
203314/002 TRESIBA INSULIN DEGLUDEC SOLUTION/SUBCUTANEOUS 600 UNITS per 3ML (200 UNITS per ML)

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
203314/001 TRESIBA INSULIN DEGLUDEC SOLUTION/SUBCUTANEOUS 300 UNITS per 3ML (100 UNITS per ML)
203314/002 TRESIBA INSULIN DEGLUDEC SOLUTION/SUBCUTANEOUS 600 UNITS per 3ML (200 UNITS per ML)

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved